SCHEMBL23799175

SCHEMBL23799175

COc1ccc2c(c1)C1(CCC(N3CCCCC3)CC1)C(=O)N2

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 1/20 0.47
ALDH1A1 P00352 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
HRH3 Q9Y5N1 1/20 0.43
FLT3 P36888 1/20 0.43
EPHX2 P34913 1/20 0.42
LRRK2 Q5S007 1/20 0.42
NQO2 P16083 1/20 0.41
OPRM1 P35372 4/20 0.41
OPRL1 P41146 3/20 0.41
OPRK1 P41145 2/20 0.41
AKR1B1 P15121 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
OTUD7B Q6GQQ9 1/20 0.39
NPC1 O15118 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23799162 0.90 FLT3 (0.42) PDE7AALDH1A1HRH3FLT3OPRM1
SCHEMBL23778269 0.87 HRH3 (0.42) PDE7AALDH1A1HRH3FLT3NQO2
SCHEMBL23798611 0.84 EPHX2 (0.44) ALDH1A1CYP2C19HRH3EPHX2OPRM1
SCHEMBL30179229 0.84 ALDH1A1 (0.47) ALDH1A1HRH3
SCHEMBL20066053 0.84 ALDH1A1 (0.47) ALDH1A1HRH3
SCHEMBL4717250 0.82 PDE7A (0.62) PDE7AAKR1B1
SCHEMBL23799149 0.81 MAOA (0.41) PDE7AHRH3FLT3OPRM1OPRL1
SCHEMBL29487409 0.81 PDE7A (0.55) PDE7AALDH1A1AKR1B1MAOAMAOB
SCHEMBL28578842 0.81 PDE7A (0.55) PDE7AALDH1A1AKR1B1MAOAMAOB
SCHEMBL23798650 0.80 NQO2 (0.38) PDE7AALDH1A1FLT3EPHX2NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3526207-B1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LTD (GB) 2021-09-08 EP disclosed